Search results
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 2 hours agoModerna stock broke out for the first time in over a year on May 2 after the biotech company notched...
J.P. Morgan downgrades Metagenomi over Moderna deal termination (NASDAQ:MGX)
Seeking Alpha· 60 minutes agoJ.P. Morgan has lowered its rating of Metagenomi (NASDAQ:MGX) to neutral, citing the recent...
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 3 hours agoModerna stock broke out for the first time in a year on Thursday after beating Wall Street's...
Moderna to seek parity for RSV shot (NASDAQ:MRNA)
Seeking Alpha· 57 minutes agoModerna (MRNA) stock gains as the company highlights its upcoming RSV shot, expecting the U.S. regulators to endorse it on par with rival products. Read more here.
...Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025 Formula, Stock Soars - ...
Benzinga· 2 hours agoThursday, Moderna Inc MRNA reported a first-quarter EPS loss of $(3.07), down from an income of...
Moderna (MRNA) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 hours agoI'll now turn the call over to Stephane. Should you invest $1,000 in Moderna right now? Before you buy stock in Moderna, consider this ...
Moderna Stock Jumps After Scoring an Earnings Beat. Next Up? Its RSV Shot.
Barrons.com· 4 hours agoModerna reported first-quarter financial results Thursday that soundly beat Wall Street...
Moderna (MRNA) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 7 hours agoModerna (MRNA) delivered earnings and revenue surprises of 14.48% and 33.88%, respectively, for the...
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 50 minutes agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 4 hours agoTotal revenues declined 91% year over year due to reduced COVID-19 vaccine sales during the quarter....